| Date | Description |
|---|
| 2024-04-06 |
delete otherexecutives Kirsty McCarthy |
| 2024-04-06 |
delete otherexecutives Stuart Onions |
| 2024-04-06 |
insert coo Andy Page |
| 2024-04-06 |
insert otherexecutives Andy Page |
| 2024-04-06 |
insert otherexecutives Emma Johnson |
| 2024-04-06 |
insert otherexecutives Marie-Claire Peakman |
| 2024-04-06 |
insert otherexecutives Rabab Nasrallah |
| 2024-04-06 |
insert otherexecutives Sally Dewhurst |
| 2024-04-06 |
insert otherexecutives Tom Lillie |
| 2024-04-06 |
insert privacy_emails pr..@gwt.bio |
| 2024-04-06 |
delete person Peter Littlewood |
| 2024-04-06 |
delete person Stuart Onions |
| 2024-04-06 |
delete person Valeriya Shunina |
| 2024-04-06 |
insert email pr..@gwt.bio |
| 2024-04-06 |
insert industry_tag drug discovery and development |
| 2024-04-06 |
insert person Andy Page |
| 2024-04-06 |
insert person Carolina Queiroz Freire |
| 2024-04-06 |
insert person Clare Sedwell |
| 2024-04-06 |
insert person Emma Johnson |
| 2024-04-06 |
insert person Faraz Khan |
| 2024-04-06 |
insert person Henry Isherwood |
| 2024-04-06 |
insert person Ionut Dragomir |
| 2024-04-06 |
insert person Kris Clark |
| 2024-04-06 |
insert person Lorena Teixeria |
| 2024-04-06 |
insert person Maria Medute |
| 2024-04-06 |
insert person Marie-Claire Peakman |
| 2024-04-06 |
insert person Natalie Hyland |
| 2024-04-06 |
insert person Rabab Nasrallah |
| 2024-04-06 |
insert person Rahul Revendran |
| 2024-04-06 |
insert person Sally Dewhurst |
| 2024-04-06 |
insert person Sam Humphrey |
| 2024-04-06 |
insert person Sam Jeskins |
| 2024-04-06 |
insert person Tom Lillie |
| 2024-04-06 |
insert person Wayne Paes |
| 2024-04-06 |
insert registration_number 10989365 |
| 2024-04-06 |
update person_description Peter Joyce => Peter Joyce |
| 2024-04-06 |
update person_title Eliot Forster: Chief Executive Officer, F - Star; ADVISOR => Independent Consultant; ADVISOR |
| 2024-04-06 |
update person_title Kirsty McCarthy: Head of Operations; Co - Founder of Both Pathios Therapeutics => Co - Founder of Both Pathios Therapeutics; Chief Executive Officer - M |
| 2024-04-06 |
update person_title Michael Pinggera: Biotech Associate => Project Support |
| 2024-04-06 |
update person_title Phill Craig: Business Analyst for M; Business Analyst => Business Intelligence Manager for M |
| 2023-11-06 |
update statutory_documents CONFIRMATION STATEMENT MADE ON 27/10/23, WITH UPDATES |
| 2023-07-07 |
update accounts_last_madeup_date 2021-12-31 => 2022-12-31 |
| 2023-07-07 |
update accounts_next_due_date 2023-09-30 => 2024-09-30 |
| 2023-06-30 |
update statutory_documents ACCOUNTS FOR 'SMALL' CO. MADE UP TO 31/12/22 |
| 2023-02-07 |
update statutory_documents 10/01/23 STATEMENT OF CAPITAL GBP 1556.7274 |
| 2023-01-24 |
update statutory_documents ADOPT ARTICLES 23/12/2022 |
| 2023-01-20 |
update statutory_documents DIRECTOR APPOINTED MS MARIE-CLAIRE PEAKMAN |
| 2023-01-20 |
update statutory_documents ARTICLES OF ASSOCIATION |
| 2023-01-19 |
update statutory_documents DIRECTOR APPOINTED DR. SALLY MARIANNE DEWHURST |
| 2023-01-19 |
update statutory_documents DIRECTOR APPOINTED MISS EMMA JOHNSON |
| 2023-01-19 |
update statutory_documents DIRECTOR APPOINTED MS RABAB NASRALLAH |
| 2022-12-09 |
update statutory_documents DIRECTOR'S CHANGE OF PARTICULARS / MR RAPHAEL WISNIEWSKI / 01/01/2022 |
| 2022-12-09 |
update statutory_documents CESSATION OF BIODISCOVERY 5 FPCI AS A PSC |
| 2022-12-09 |
update statutory_documents CESSATION OF CANAAN XI L.P. AS A PSC |
| 2022-12-09 |
update statutory_documents NOTIFICATION OF PSC STATEMENT ON 29/03/2018 |
| 2022-10-27 |
update statutory_documents CONFIRMATION STATEMENT MADE ON 27/10/22, WITH UPDATES |
| 2022-10-20 |
update statutory_documents AUTHORISED ALLOTMENT OF SHARES AND DEBENTURES |
| 2022-09-13 |
update statutory_documents AUTHORITY- PURCHASE SHARES OTHER THAN FROM CAPITAL |
| 2022-09-13 |
update statutory_documents AUTHORITY- PURCHASE SHARES OTHER THAN FROM CAPITAL |
| 2022-09-12 |
update statutory_documents RETURN OF PURCHASE OF OWN SHARES |
| 2022-09-12 |
update statutory_documents 31/08/22 STATEMENT OF CAPITAL GBP 843.0161 |
| 2022-09-07 |
delete address CLARENDON BUSINESS CENTRE 57 WOODSTOCK ROAD OXFORD ENGLAND OX2 6HJ |
| 2022-09-07 |
insert address 99 PARK DRIVE MILTON ABINGDON ENGLAND OX14 4RY |
| 2022-09-07 |
update registered_address |
| 2022-08-04 |
update statutory_documents REGISTERED OFFICE CHANGED ON 04/08/2022 FROM
CLARENDON BUSINESS CENTRE 57 WOODSTOCK ROAD
OXFORD
OX2 6HJ
ENGLAND |
| 2022-07-11 |
update statutory_documents SECRETARY APPOINTED MS SAMANTHA ANN HARRIS |
| 2022-06-07 |
update accounts_last_madeup_date 2020-12-31 => 2021-12-31 |
| 2022-06-07 |
update accounts_next_due_date 2022-09-30 => 2023-09-30 |
| 2022-06-06 |
update statutory_documents AUTHORITY- PURCHASE SHARES OTHER THAN FROM CAPITAL |
| 2022-05-30 |
update statutory_documents 19/05/22 STATEMENT OF CAPITAL GBP 843.3515 |
| 2022-05-30 |
update statutory_documents RETURN OF PURCHASE OF OWN SHARES |
| 2022-05-30 |
update statutory_documents 19/05/22 STATEMENT OF CAPITAL GBP 842.9184 |
| 2022-05-13 |
update statutory_documents ACCOUNTS FOR 'SMALL' CO. MADE UP TO 31/12/21 |
| 2022-03-11 |
delete source_ip 178.62.87.158 |
| 2022-03-11 |
insert person Georgia Palmer |
| 2022-03-11 |
insert person Joana Ribeiro |
| 2022-03-11 |
insert person Lisa Shoesmith |
| 2022-03-11 |
insert person Michael Pinggera |
| 2022-03-11 |
insert person Peter Littlewood |
| 2022-03-11 |
insert person Phill Craig |
| 2022-03-11 |
insert person Sam Harris |
| 2022-03-11 |
insert person Valeriya Shunina |
| 2022-03-11 |
insert source_ip 151.101.66.159 |
| 2022-03-11 |
update robots_txt_status www.greywolftherapeutics.com: 200 => 0 |
| 2022-03-02 |
update statutory_documents 22/02/22 STATEMENT OF CAPITAL GBP 843.9393 |
| 2022-01-14 |
update statutory_documents 22/12/21 STATEMENT OF CAPITAL GBP 843.5062 |
| 2021-12-06 |
update person_description Stuart Hughes => Stuart Hughes |
| 2021-12-06 |
update person_title Stuart Hughes: Senior Director and Head of Pharmacology at Vertex Pharmaceuticals Europe Ltd; Chief Executive Officer, Pathios Therapeutics; ADVISOR => Chief Executive Officer, Pathios Therapeutics; ADVISOR |
| 2021-11-11 |
update statutory_documents CESSATION OF PETER JOYCE AS A PSC |
| 2021-11-11 |
update statutory_documents CESSATION OF THOMAS DAVID MCCARTHY AS A PSC |
| 2021-10-29 |
update statutory_documents CONFIRMATION STATEMENT MADE ON 29/10/21, WITH UPDATES |
| 2021-10-12 |
update statutory_documents 08/10/21 STATEMENT OF CAPITAL GBP 838.6639 |
| 2021-09-29 |
update statutory_documents CONFIRMATION STATEMENT MADE ON 28/09/21, WITH UPDATES |
| 2021-09-07 |
update person_title Dr. John Castle: Associate Vice President, Head of Translational Sciences; ADVISOR; Head of Translational Medicine and Bioinformatics, Agenus => Chief Data Science Officer at Monte Rosa Therapeutics; ADVISOR |
| 2021-07-08 |
delete contact_pages_linkeddomain brightnetwork.co.uk |
| 2021-07-08 |
delete person Ben Skead |
| 2021-07-08 |
delete registration_number 10989365 |
| 2021-07-08 |
delete vat 285 6169 64 |
| 2021-07-08 |
insert terms_pages_linkeddomain egnyte.com |
| 2021-06-24 |
update statutory_documents DIRECTOR'S CHANGE OF PARTICULARS / MR PETER JOYCE / 28/05/2021 |
| 2021-06-08 |
insert contact_pages_linkeddomain brightnetwork.co.uk |
| 2021-05-07 |
update accounts_last_madeup_date 2019-12-31 => 2020-12-31 |
| 2021-05-07 |
update accounts_next_due_date 2021-09-30 => 2022-09-30 |
| 2021-04-20 |
update statutory_documents ACCOUNTS FOR 'SMALL' CO. MADE UP TO 31/12/20 |
| 2021-04-15 |
delete coo Kirsty McCarthy |
| 2021-04-15 |
insert otherexecutives Kirsty McCarthy |
| 2021-04-15 |
delete industry_tag drug discovery biotechnology |
| 2021-04-15 |
insert person Andrea Richardson |
| 2021-04-15 |
insert person Ben Skead |
| 2021-04-15 |
insert person Jessica Sette |
| 2021-04-15 |
insert person Kate Anderton |
| 2021-04-15 |
update founded_year null => 2017 |
| 2021-04-15 |
update person_description Dr. John Castle => Dr. John Castle |
| 2021-04-15 |
update person_title Anil Singhal: Board Member, TriSalus Life Sciences; ADVISOR => CEO, Adicet Bio; ADVISOR |
| 2021-04-15 |
update person_title Dr. John Castle: Expert; Chief Data Scientist, Monte Rosa Therapeutics; ADVISOR => Associate Vice President, Head of Translational Sciences; ADVISOR; Head of Translational Medicine and Bioinformatics, Agenus |
| 2021-04-15 |
update person_title John Pollard: VP, Global Head of Translational Medicine Oncology, Bayer Pharmaceuticals; Principal Research Fellow, Vice President and Head of Biological Sciences at Vertex Pharmaceuticals; ADVISOR => Principal Research Fellow, Vice President and Head of Biological Sciences at Vertex Pharmaceuticals; ADVISOR; VP, Vertex Pharmaceuticals |
| 2021-04-15 |
update person_title Kirsty McCarthy: Chief Operating Officer; Co - Founder of Both Pathios Therapeutics => Head of Operations; Co - Founder of Both Pathios Therapeutics |
| 2021-04-15 |
update person_title Nicola Ternette: ADVISOR; Associate Professor, Antigen Discovery, University of Oxford => Head of Immunopeptidomics, University of Oxford; ADVISOR |
| 2021-04-08 |
update statutory_documents SECOND FILED SH01 - 24/03/21 STATEMENT OF CAPITAL GBP 752.7661 |
| 2021-04-06 |
update statutory_documents 24/03/21 STATEMENT OF CAPITAL GBP 752.7661 |
| 2021-02-02 |
update statutory_documents RETURN OF PURCHASE OF OWN SHARES |
| 2021-02-02 |
update statutory_documents 05/01/21 STATEMENT OF CAPITAL GBP 739.0348 |
| 2021-01-28 |
update statutory_documents AUTHORITY- PURCHASE SHARES OTHER THAN FROM CAPITAL |
| 2021-01-20 |
delete cfo Bill Fleming |
| 2021-01-20 |
delete person Bill Fleming |
| 2021-01-20 |
delete person Lesley Young |
| 2021-01-20 |
update person_description Dr. John Castle => Dr. John Castle |
| 2021-01-20 |
update person_title Anil Singhal: CEO, Adicet Bio; ADVISOR => Board Member, TriSalus Life Sciences; ADVISOR |
| 2021-01-20 |
update person_title Dr. John Castle: Associate Vice President, Head of Translational Sciences; ADVISOR; Head of Translational Medicine and Bioinformatics, Agenus => Expert; Chief Data Scientist, Monte Rosa Therapeutics; ADVISOR |
| 2021-01-20 |
update person_title Dr. Nicola Ternette: Head of Immunopeptidomics, University of Oxford; ADVISOR => ADVISOR; Associate Professor, Antigen Discovery, University of Oxford |
| 2021-01-20 |
update person_title John Pollard: Principal Research Fellow, Vice President and Head of Biological Sciences at Vertex Pharmaceuticals; ADVISOR; VP, Vertex Pharmaceuticals => VP, Global Head of Translational Medicine Oncology, Bayer Pharmaceuticals; Principal Research Fellow, Vice President and Head of Biological Sciences at Vertex Pharmaceuticals; ADVISOR |
| 2020-11-27 |
update statutory_documents ARTICLES OF ASSOCIATION |
| 2020-11-27 |
update statutory_documents ADOPT ARTICLES 20/11/2020 |
| 2020-11-27 |
update statutory_documents 20/11/20 STATEMENT OF CAPITAL GBP 739.8760 |
| 2020-10-26 |
update statutory_documents RETURN OF PURCHASE OF OWN SHARES |
| 2020-10-26 |
update statutory_documents 16/10/20 STATEMENT OF CAPITAL GBP 580.3515 |
| 2020-10-07 |
update statutory_documents CONFIRMATION STATEMENT MADE ON 28/09/20, WITH UPDATES |
| 2020-09-30 |
delete otherexecutives Kirsty McCarthy |
| 2020-09-30 |
insert coo Kirsty McCarthy |
| 2020-09-30 |
update person_title Kirsty McCarthy: Head of Operations; Co - Founder of Both Pathios Therapeutics => Chief Operating Officer; Co - Founder of Both Pathios Therapeutics |
| 2020-08-09 |
update accounts_last_madeup_date 2018-12-31 => 2019-12-31 |
| 2020-08-09 |
update accounts_next_due_date 2020-12-31 => 2021-09-30 |
| 2020-07-13 |
update statutory_documents ACCOUNTS FOR 'SMALL' CO. MADE UP TO 31/12/19 |
| 2020-07-07 |
update accounts_next_due_date 2020-09-30 => 2020-12-31 |
| 2020-06-22 |
update statutory_documents 15/06/20 STATEMENT OF CAPITAL GBP 0.5916 |
| 2020-06-20 |
insert person Nicola Ternette |
| 2020-05-21 |
insert index_pages_linkeddomain linkedin.com |
| 2020-04-20 |
update person_title Stuart Hughes: Senior Director and Head of Pharmacology at Vertex Pharmaceuticals Europe Ltd; Member of the ADVISORY BOARD; Chief Executive Office, Pathios Therapeutics => Senior Director and Head of Pharmacology at Vertex Pharmaceuticals Europe Ltd; Chief Executive Officer, Pathios Therapeutics; Member of the ADVISORY BOARD |
| 2020-03-31 |
update statutory_documents 04/03/20 STATEMENT OF CAPITAL GBP 580.7550 |
| 2020-03-21 |
insert registration_number 10989365 |
| 2020-03-21 |
insert vat 285 6169 64 |
| 2020-02-19 |
delete contact_pages_linkeddomain google.com |
| 2020-02-19 |
insert address Milton Park Innovation Centre
99 Park Drive, Milton Park
Abingdon, OX14 4RY, UK |
| 2020-01-23 |
update statutory_documents 13/01/20 STATEMENT OF CAPITAL GBP 573.2484 |
| 2020-01-21 |
update statutory_documents ADOPT ARTICLES 08/01/2020 |
| 2020-01-21 |
update statutory_documents 08/01/20 STATEMENT OF CAPITAL GBP 504.0729 |
| 2020-01-17 |
update statutory_documents RETURN OF PURCHASE OF OWN SHARES |
| 2020-01-12 |
delete associated_investor Canaan Partners |
| 2020-01-12 |
delete email se..@greywolftherapeutics.com |
| 2020-01-12 |
delete registration_number 10989365 |
| 2020-01-12 |
delete vat 285 6169 64 |
| 2020-01-12 |
insert contact_pages_linkeddomain google.com |
| 2020-01-12 |
update person_title Anil Singhal: Venture Partner, Canaan; Member of the ADVISORY BOARD => CEO, Adicet Bio; Member of the ADVISORY BOARD |
| 2020-01-12 |
update person_title Stuart Hughes: Senior Director and Head of Pharmacology at Vertex Pharmaceuticals Europe Ltd; Member of the ADVISORY BOARD; Director, Head of Pharmacology, Vertex Pharmaceuticals => Senior Director and Head of Pharmacology at Vertex Pharmaceuticals Europe Ltd; Member of the ADVISORY BOARD; Chief Executive Office, Pathios Therapeutics |
| 2019-11-12 |
insert otherexecutives Kirsty McCarthy |
| 2019-11-12 |
delete person Korinna Pilz |
| 2019-11-12 |
insert person Kirsty McCarthy |
| 2019-10-03 |
update statutory_documents CONFIRMATION STATEMENT MADE ON 28/09/19, WITH UPDATES |
| 2019-07-17 |
update statutory_documents DOCUMENT REMOVED |
| 2019-07-06 |
update statutory_documents 01/07/19 STATEMENT OF CAPITAL GBP 504.4324 |
| 2019-06-20 |
update account_category NO ACCOUNTS FILED => SMALL |
| 2019-06-20 |
update accounts_last_madeup_date null => 2018-12-31 |
| 2019-06-20 |
update accounts_next_due_date 2019-06-29 => 2020-09-30 |
| 2019-06-06 |
update statutory_documents 31/05/19 STATEMENT OF CAPITAL GBP 502.1877 |
| 2019-05-20 |
update statutory_documents DISAPPLICATION OF PRE-EMPTION RIGHTS |
| 2019-05-15 |
update statutory_documents ACCOUNTS FOR 'SMALL' CO. MADE UP TO 31/12/18 |
| 2019-05-03 |
update statutory_documents SECOND FILED SH01 - 09/12/18 STATEMENT OF CAPITAL GBP 318.9795 |
| 2019-05-03 |
update statutory_documents SECOND FILED SH01 - 10/10/18 STATEMENT OF CAPITAL GBP 317.0223 |
| 2019-05-03 |
update statutory_documents SECOND FILED SH01 - 29/10/18 STATEMENT OF CAPITAL GBP 318.8164 |
| 2019-03-18 |
update statutory_documents NOTIFICATION OF A PERSON WITH SIGNIFICANT CONTROL CANAAN XI L.P. |
| 2019-03-08 |
update statutory_documents NOTIFICATION OF A PERSON WITH SIGNIFICANT CONTROL BIODISCOVERY 5 FPCI |
| 2019-02-25 |
update statutory_documents 12/02/19 STATEMENT OF CAPITAL GBP 498.8356 |
| 2018-12-10 |
update statutory_documents 09/12/18 STATEMENT OF CAPITAL GBP 318.9795 |
| 2018-10-30 |
update statutory_documents 29/10/18 STATEMENT OF CAPITAL GBP 318.8164 |
| 2018-10-10 |
update statutory_documents CONFIRMATION STATEMENT MADE ON 28/09/18, WITH UPDATES |
| 2018-10-10 |
update statutory_documents 10/10/18 STATEMENT OF CAPITAL GBP 317.0194 |
| 2018-05-18 |
update statutory_documents ARTICLES OF ASSOCIATION |
| 2018-04-23 |
update statutory_documents ARTICLES OF ASSOCIATION |
| 2018-04-19 |
update statutory_documents 29/03/18 STATEMENT OF CAPITAL GBP 313.1894 |
| 2018-04-12 |
update statutory_documents ADOPT ARTICLES 29/03/2018 |
| 2018-04-07 |
update account_ref_day 30 => 31 |
| 2018-04-07 |
update account_ref_month 9 => 12 |
| 2018-04-05 |
update statutory_documents DIRECTOR APPOINTED MR BRENTON KARL AHRENS |
| 2018-04-03 |
update statutory_documents DIRECTOR APPOINTED DR THIERRY HERCEND |
| 2018-04-03 |
update statutory_documents DIRECTOR APPOINTED MR RAPHAEL WISNIEWSKI |
| 2018-04-03 |
update statutory_documents APPOINTMENT TERMINATED, DIRECTOR STUART ONIONS |
| 2018-03-22 |
update statutory_documents CURREXT FROM 30/09/2018 TO 31/12/2018 |
| 2018-03-22 |
update statutory_documents DIRECTOR APPOINTED MR STUART THOMAS ONIONS |
| 2018-03-19 |
update statutory_documents AUTHORISED ALLOTMENT OF SHARES AND DEBENTURES |
| 2018-03-19 |
update statutory_documents 14/03/18 STATEMENT OF CAPITAL GBP 133.3333 |
| 2018-03-15 |
update statutory_documents ADOPT ARTICLES 16/02/2018 |
| 2018-03-14 |
update statutory_documents SUB-DIVISION
16/02/18 |
| 2018-03-12 |
update statutory_documents SECOND FILED SH01 - 03/11/17 STATEMENT OF CAPITAL GBP 116.2963 |
| 2018-03-12 |
update statutory_documents SECOND FILED SH01 - 17/11/17 STATEMENT OF CAPITAL GBP 120 |
| 2017-11-23 |
update statutory_documents 17/11/17 STATEMENT OF CAPITAL GBP 216.311118 |
| 2017-11-21 |
update statutory_documents 16/11/17 STATEMENT OF CAPITAL GBP 216.29 |
| 2017-09-29 |
update statutory_documents CERTIFICATE OF INCORPORATION
GENERAL COMPANY DETAILS & STATEMENTS OF;
OFFICERS, CAPITAL & SHAREHOLDINGS, GUARANTEE, COMPLIANCE
MEMORANDUM OF ASSOCIATION
ARTICLES OF ASSOCIATION |